Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Nephrology (kidneys)

  • Article

    Associations of Apixaban Dose with Safety and Effectiveness Outcomes in Patients with Atrial Fibrillation and Severe CKD

    April 1, 2024

    Clinical question: Is the use of standard-dose apixaban based on creatinine criteria placing patients at higher risk of bleeding? Background: The U.S. Food and Drug Administration recommends...

  • Article

    Risk for CKD Progression After AKI

    February 1, 2024

    Dr. Dalal Clinical question:  Is acute kidney injury (AKI) associated with subsequent worsening of renal function trajectory in patients with chronic kidney disease (CKD)?  Background: Prior...

  • Article

    Apixaban Has Lower Risk of Bleeding Than Warfarin in ESKD

    June 1, 2023

    Dr. Leiner Clinical question: In patients with end-stage kidney disease (ESKD) and venous thromboembolism (VTE), does apixaban have a lower bleeding risk and VTE recurrence than...

  • Article

    Early Initiation of Dialysis Improves Survival: To Start or Not to Start

    March 1, 2023

    Clinical question: What is the ideal estimated glomerular filtration rate (eGFR) at which to start dialysis in patients with advanced chronic kidney disease? Background: Uncertainty exists over the...

  • Article

    Prediction of End-stage Kidney Disease Using Estimated Glomerular Filtration Rate With and Without Race

    October 3, 2022

    Dr. Choksi Clinical question: Does using old and new chronic kidney disease epidemiology collaboration (CKD-EPI) equations alone have a better predictive value for two-year incidence of end-stage...

  • Article

    Can I use DOAC in a patient with renal disease?

    February 3, 2022

    Case A 76-year-old man is diagnosed with non-valvular atrial fibrillation. His comorbid conditions are hypertension, diabetes complicated by neuropathy, and chronic kidney disease stage 3. His...

  • 1
    News

    Apixaban a reasonable alternative to warfarin in patients with severe renal impairment

    December 9, 2021

    Is apixaban a safe alternative to warfarin in patients with severe renal impairment?

  • 1
    News

    Timing of initiation of renal-replacement therapy in acute kidney injury

    December 8, 2021

    In critically ill patients, does early renal-replacement therapy (RRT), compared with standard therapy, improve death from any cause at 90 days?

  • 1
    News

    Comparing the efficacy and safety of common SIADH treatments

    November 24, 2021

    Is fluid restriction or the addition of furosemide with or without NaCl supplementation more efficacious for the treatment of hyponatremia caused by syndrome of inappropriate antidiuretic hormone (SIADH)?

  • News

    Acute urinary retention tied to increased risk of certain cancers

    November 24, 2021

    “Admission with a first-time acute urinary retention could be an opportunity to diagnose an occult cancer.”

Previous1 2 3 4 … 9Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences